Patterns and Medical Resource Utilization after Generic Switching in Antiepileptic Drugs - A Review of the Quebec Experience

¹Pharmacoepidemiology and Pharmacoeconomic Unit, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada;

²Analysis Group, Boston, MA, United States;

^3,4,5Groupe d'analyse, Ltée, Montreal, QC, Canada;

⁶GlaxoSmithKline, RTP, NC, United States;

⁷Pharmacoepidemiology and Pharmacoeconomic Unit, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.